Rifampicin ($RIF) Price Prediction 2025–2030
Discover Rifampicin ($RIF) price forecasts for 2025. Get insights into long-term predictions up to 2026-2030
Discover Rifampicin ($RIF) price forecasts for 2025. Get insights into long-term predictions up to 2026-2030
Discover the current and predicted price of Rifampicin ($RIF). Analyze important metrics such as green days and 50-day SMA to assess market sentiment.
50-day SMA The 50-day SMA is the average closing price of $RIF over the past 50 days, used to assess trends. $0 | 200-day SMA The 200-day SMA is the average closing price of $RIF over the past 200 days. Its a key indicator used to identify long-term price trends. $0.01000 | Volatility Volatility measures the price fluctuation of $RIF over the last 30 days. Higher volatility indicates greater price swings and potentially higher risk. 34.45 | Down Days Down Days represent the number of days in the past 30 where the closing price of $RIF was lower than its opening price, indicating negative price movement. 17 | Green Days Green Days are the days when $RIF closed higher than it opened, indicating positive price movement. 13 |
Discover short-term price predictions for Rifampicin ($RIF). Check forecasted prices for today, tomorrow, and the next 30 days to guide your trading strategy.
Date | High | Low | End | Potential ROI |
---|---|---|---|---|
2025-07-20 | $0.002370 | $0.002318 | $0.002318 | -2.98 % |
2025-07-21 | $0.002370 | $0.002318 | $0.002331 | -2.98 % |
2025-07-20 | $0.002370 | $0.002318 | $0.002318 | -2.98 % |
2025-07-31 | $0.002579 | $0.002220 | $0.002420 | 5.51 % |
Discover short-term price targets for Rifampicin ($RIF), with predictions for each day in the next 30 days. Potential ROI is provided for every target.
Date | Price | Potential ROI |
---|---|---|
2025-07-19 | $0.002370 | -2.98 % |
2025-07-20 | $0.002318 | -5.1 % |
2025-07-21 | $0.002331 | -4.63 % |
2025-07-22 | $0.002266 | -7.25 % |
2025-07-23 | $0.002220 | -9.11 % |
2025-07-24 | $0.002259 | -7.58 % |
2025-07-25 | $0.002386 | -2.35 % |
2025-07-26 | $0.002484 | 1.66 % |
2025-07-27 | $0.002530 | 3.5 % |
2025-07-28 | $0.002579 | 5.51 % |
2025-07-29 | $0.002484 | 1.68 % |
2025-07-30 | $0.002475 | 1.31 % |
2025-07-31 | $0.002420 | -0.95 % |
2025-08-01 | $0.002357 | -3.53 % |
2025-08-02 | $0.002413 | -1.24 % |
2025-08-03 | $0.002419 | -1.01 % |
2025-08-04 | $0.002400 | -1.75 % |
2025-08-05 | $0.002462 | 0.79 % |
2025-08-06 | $0.002441 | -0.14 % |
2025-08-07 | $0.002415 | -1.18 % |
2025-08-08 | $0.002377 | -2.74 % |
2025-08-09 | $0.002406 | -1.56 % |
2025-08-10 | $0.002405 | -1.61 % |
2025-08-11 | $0.002373 | -2.92 % |
2025-08-12 | $0.002435 | -0.36 % |
2025-08-13 | $0.002456 | 0.54 % |
2025-08-14 | $0.002291 | -6.26 % |
2025-08-15 | $0.002217 | -9.26 % |
2025-08-16 | $0.002223 | -9.03 % |
2025-08-17 | $0.002284 | -6.56 % |
2025-08-18 | $0.002304 | -5.74 % |
Discover long-term price forecasts for Rifampicin ($RIF) for 2026-2030. Future prices and potential ROI are estimated year-by-year to help guide your investment strategy.
Year | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
2025 | $0.002579 | $0.001889 | $0.002178 | 5.51 % |
2026 | $0.002861 | $0.001806 | $0.002275 | 17.1 % |
2027 | $0.002661 | $0.001827 | $0.002285 | 8.88 % |
2028 | $0.002595 | $0.001735 | $0.002174 | 6.19 % |
2029 | $0.002593 | $0.001771 | $0.002214 | 6.12 % |
2030 | $0.002822 | $0.001716 | $0.002295 | 15.5 % |
2031 | $0.002147 | $0.002052 | $0.002090 | -12.15 % |
For 2025, Rifampicin ($RIF) is forecasted to range between $0.001889 and $0.002579. December could be the most bullish month, with potential growth of 5.51.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
July | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
August | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
September | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
October | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
November | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
December | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
For 2026, Rifampicin ($RIF) is forecasted to range between $0.001806 and $0.002862. December could be the most bullish month, with potential growth of 17.1.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
February | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
March | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
April | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
May | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
June | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
July | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
August | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
September | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
October | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
November | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
December | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
For 2027, Rifampicin ($RIF) is forecasted to range between $0.001828 and $0.002661. December could be the most bullish month, with potential growth of 8.88.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
February | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
March | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
April | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
May | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
June | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
July | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
August | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
September | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
October | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
November | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
December | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
For 2028, Rifampicin ($RIF) is forecasted to range between $0.001735 and $0.002595. December could be the most bullish month, with potential growth of 6.19.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
February | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
March | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
April | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
May | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
June | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
July | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
August | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
September | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
October | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
November | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
December | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
For 2029, Rifampicin ($RIF) is forecasted to range between $0.001771 and $0.002594. December could be the most bullish month, with potential growth of 6.12.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
February | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
March | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
April | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
May | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
June | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
July | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
August | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
September | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
October | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
November | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
December | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
For 2030, Rifampicin ($RIF) is forecasted to range between $0.001716 and $0.002823. December could be the most bullish month, with potential growth of 15.5.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
February | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
March | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
April | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
May | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
June | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
July | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
August | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
September | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
October | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
November | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
December | $-12.15 | $-12.15 | $-12.15 | -12.15 % |
For 2031, Rifampicin ($RIF) is forecasted to range between $0.002052 and $0.002147. December could be the most bullish month, with potential growth of -12.15.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-12.15 | $-12.15 | $-12.15 | -12.15 % |